Roth Capital Reinstates Buy on Monopar Therapeutics, Announces $18 Price Target
Roth Capital analyst Kumaraguru Raja reinstates Monopar Therapeutics (NASDAQ:MNPR) with a Buy and announces $18 price target.
Chardan Capital Initiates Coverage On Presto Technologies with Neutral Rating, Announces Price Target of $4.25
Chardan Capital analyst Brian Dobson initiates coverage on Presto Technologies (NASDAQ:PRST) with a Neutral rating and announces Price Target of $4.25.
Stephens & Co. Reinstates Overweight on Orange County Bancorp, Announces $50 Price Target
Stephens & Co. analyst Matt Breese reinstates Orange County Bancorp (NASDAQ:OBT) with a Overweight and announces $50 price target.
Morgan Stanley Initiates Coverage On RXO with Equal-Weight Rating, Announces Price Target of $20
Morgan Stanley analyst Ravi Shanker initiates coverage on RXO (NYSE:RXO) with a Equal-Weight rating and announces Price Target of $20.
Mizuho Assumes Karuna Therapeutics at Buy, Lowers Price Target of $270
Mizuho analyst Graig Suvannavejh assumes Karuna Therapeutics (NASDAQ:KRTX) with a Buy rating and lowers Price Target of $270.
Canaccord Genuity Initiates Coverage On AgileThought with Buy Rating, Announces Price Target of $7
Canaccord Genuity analyst Joseph Vafi initiates coverage on AgileThought (NASDAQ:AGIL) with a Buy rating and announces Price Target of $7.
Cantor Fitzgerald Initiates Coverage On Cleanspark with Overweight Rating, Announces Price Target of $5
Cantor Fitzgerald analyst Josh Siegler initiates coverage on Cleanspark (NASDAQ:CLSK) with a Overweight rating and announces Price Target of $5.
Morgan Stanley Initiates Coverage On Silence Therapeutics with Equal-Weight Rating, Announces Price Target of $18
Morgan Stanley analyst Andrew Galler initiates coverage on Silence Therapeutics (NASDAQ:SLN) with a Equal-Weight rating and announces Price Target of $18.
Citigroup Initiates Coverage On Crestwood Equity Partners with Buy Rating, Announces Price Target of $32
Citigroup analyst Spiro Dounis initiates coverage on Crestwood Equity Partners (NYSE:CEQP) with a Buy rating and announces Price Target of $32.
Citigroup Initiates Coverage On Kinetik Holdings with Buy Rating, Announces Price Target of $36
Citigroup analyst Spiro Dounis initiates coverage on Kinetik Holdings (NYSE:KNTK) with a Buy rating and announces Price Target of $36.